96938-51-1,MFCD00432860
Catalog No.:AA0065MO

96938-51-1 | N-[(6-Methylpyridin-2-yl)carbamothioyl]benzamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95+%
2 weeks  
$85.00   $60.00
- +
250mg
95+%
2 weeks  
$108.00   $75.00
- +
1g
95+%
2 weeks  
$233.00   $163.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0065MO
Chemical Name:
N-[(6-Methylpyridin-2-yl)carbamothioyl]benzamide
CAS Number:
96938-51-1
Molecular Formula:
C14H13N3OS
Molecular Weight:
271.3375
MDL Number:
MFCD00432860
SMILES:
S=C(NC(=O)c1ccccc1)Nc1cccc(n1)C
NSC Number:
249309
Properties
Properties
 
Form:
Solid  
MP:
131.70-132.95℃(Solv: ethanol (64-17-5); water (7732-18-5))  
Storage:
Inert atmosphere;2-8℃;  

Computed Properties
 
Complexity:
329  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3.2  

Upstream Synthesis Route

[1]Patent:WO2013/33037,2013,A2,.Locationinpatent:Paragraph0752

[2]JournalofHeterocyclicChemistry,1985,vol.22,#1,p.137-140

[3]BioorganicandMedicinalChemistryLetters,2005,vol.15,#12,p.3081-3085

[4]Patent:WO2005/95345,2005,A2,.Locationinpatent:Page/Pagecolumn41

[5]BioorganicandMedicinalChemistryLetters,2008,vol.18,#2,p.634-639

[6]ChemMedChem,2013,vol.8,#5,p.847-857

[7]BioorganicandMedicinalChemistry,2013,vol.21,#21,p.6385-6397

[8]Phosphorus,SulfurandSiliconandtheRelatedElements,2015,vol.190,#8,p.1366-1377

[1]DaltonTransactions,2014,vol.43,#21,p.7945-7957

[1]Phosphorus,SulfurandSiliconandtheRelatedElements,2015,vol.190,#8,p.1366-1377

[1]BioorganicandMedicinalChemistry,2011,vol.19,#1,p.156-167

Downstream Synthesis Route

[1]Patent:WO2013/33037,2013,A2.Locationinpatent:Paragraph0752

[2]JournalofHeterocyclicChemistry,1985,vol.22,p.137-140

[3]BioorganicandMedicinalChemistryLetters,2005,vol.15,p.3081-3085

[4]Patent:WO2005/95345,2005,A2.Locationinpatent:Page/Pagecolumn41

[5]BioorganicandMedicinalChemistryLetters,2008,vol.18,p.634-639

[6]ChemMedChem,2013,vol.8,p.847-857

[7]BioorganicandMedicinalChemistry,2013,vol.21,p.6385-6397

[8]Phosphorus,SulfurandSiliconandtheRelatedElements,2015,vol.190,p.1366-1377

[1]JournalofHeterocyclicChemistry,1985,vol.22,p.725-728

[1]Patent:WO2013/33037,2013,A2.Locationinpatent:Paragraph0752

[2]BioorganicandMedicinalChemistryLetters,2005,vol.15,p.3081-3085

[3]BioorganicandMedicinalChemistryLetters,2008,vol.18,p.634-639

[4]BioorganicandMedicinalChemistry,2011,vol.19,p.156-167

[5]ChemMedChem,2013,vol.8,p.847-857

[6]BioorganicandMedicinalChemistry,2013,vol.21,p.6385-6397

[1]BioorganicandMedicinalChemistryLetters,2005,vol.15,p.3081-3085

[1]BioorganicandMedicinalChemistryLetters,2005,vol.15,p.3081-3085

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:96938-51-1 Molecular Formula|96938-51-1 MDL|96938-51-1 SMILES|96938-51-1 N-[(6-Methylpyridin-2-yl)carbamothioyl]benzamide
Catalog No.: AA0065MO
96938-51-1,MFCD00432860
96938-51-1 | N-[(6-Methylpyridin-2-yl)carbamothioyl]benzamide
Pack Size: 100mg
Purity: 95+%
2 weeks
$85.00 $60.00
Pack Size: 250mg
Purity: 95+%
2 weeks
$108.00 $75.00
Pack Size: 1g
Purity: 95+%
2 weeks
$233.00 $163.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0065MO
Chemical Name: N-[(6-Methylpyridin-2-yl)carbamothioyl]benzamide
CAS Number: 96938-51-1
Molecular Formula: C14H13N3OS
Molecular Weight: 271.3375
MDL Number: MFCD00432860
SMILES: S=C(NC(=O)c1ccccc1)Nc1cccc(n1)C
NSC Number: 249309
Properties
Form: Solid  
MP: 131.70-132.95℃(Solv: ethanol (64-17-5); water (7732-18-5))  
Storage: Inert atmosphere;2-8℃;  
Complexity: 329  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 19  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3.2  
Upstream Synthesis Route
1824-81-3    532-55-8    96938-51-1 

[1]Patent:WO2013/33037,2013,A2,.Locationinpatent:Paragraph0752

[2]JournalofHeterocyclicChemistry,1985,vol.22,#1,p.137-140

[3]BioorganicandMedicinalChemistryLetters,2005,vol.15,#12,p.3081-3085

[4]Patent:WO2005/95345,2005,A2,.Locationinpatent:Page/Pagecolumn41

[5]BioorganicandMedicinalChemistryLetters,2008,vol.18,#2,p.634-639

[6]ChemMedChem,2013,vol.8,#5,p.847-857

[7]BioorganicandMedicinalChemistry,2013,vol.21,#21,p.6385-6397

[8]Phosphorus,SulfurandSiliconandtheRelatedElements,2015,vol.190,#8,p.1366-1377

1824-81-3    333-20-0    98-88-4    96938-51-1 

[1]DaltonTransactions,2014,vol.43,#21,p.7945-7957

65-85-0    96938-51-1 

[1]Phosphorus,SulfurandSiliconandtheRelatedElements,2015,vol.190,#8,p.1366-1377

1824-81-3    98-88-4    96938-51-1 

[1]BioorganicandMedicinalChemistry,2011,vol.19,#1,p.156-167

Downstream Synthesis Route
1824-81-3    532-55-8    96938-51-1 

[1]Patent:WO2013/33037,2013,A2.Locationinpatent:Paragraph0752

[2]JournalofHeterocyclicChemistry,1985,vol.22,p.137-140

[3]BioorganicandMedicinalChemistryLetters,2005,vol.15,p.3081-3085

[4]Patent:WO2005/95345,2005,A2.Locationinpatent:Page/Pagecolumn41

[5]BioorganicandMedicinalChemistryLetters,2008,vol.18,p.634-639

[6]ChemMedChem,2013,vol.8,p.847-857

[7]BioorganicandMedicinalChemistry,2013,vol.21,p.6385-6397

[8]Phosphorus,SulfurandSiliconandtheRelatedElements,2015,vol.190,p.1366-1377

96938-51-1    100856-70-0 

[1]JournalofHeterocyclicChemistry,1985,vol.22,p.725-728

96938-51-1    49600-34-2 

[1]Patent:WO2013/33037,2013,A2.Locationinpatent:Paragraph0752

[2]BioorganicandMedicinalChemistryLetters,2005,vol.15,p.3081-3085

[3]BioorganicandMedicinalChemistryLetters,2008,vol.18,p.634-639

[4]BioorganicandMedicinalChemistry,2011,vol.19,p.156-167

[5]ChemMedChem,2013,vol.8,p.847-857

[6]BioorganicandMedicinalChemistry,2013,vol.21,p.6385-6397

96938-51-1    861883-80-9 

[1]BioorganicandMedicinalChemistryLetters,2005,vol.15,p.3081-3085

96938-51-1    861883-81-0 

[1]BioorganicandMedicinalChemistryLetters,2005,vol.15,p.3081-3085

Building Blocks More >
99043-04-6
99043-04-6
Mycophenolic Acid Acyl-β-D-glucuronide
AA0066D7 | MFCD11977846
98648-34-1
98648-34-1
N-METHYL-N-NITROSO HEXADECYLAMINE
AA00678X | MFCD02258719
92901-94-5
92901-94-5
(2,5-Dimethyl-1,3-oxazol-4-yl)methanol
AA00683A | MFCD07772804
893736-92-0
893736-92-0
3-(Benzyloxy)-2'-cyanobiphenyl
AA00691V | MFCD06802288
7126-44-5
7126-44-5
Ethyl 3-cyano-1h-pyrrole-2-carboxylate
AA0069TW | MFCD12756171
907958-42-3
907958-42-3
4-Chloro-5-nitro-1h-indazole
AA006AE0 | MFCD11007841
913835-88-8
913835-88-8
Ethyl 3-borono-5-bromobenzoate
AA006BEY | MFCD08689516
70128-09-5
70128-09-5
5-METHYL-2-(METHYLAMINO)BENZALDEHYDE
AA006C0X | MFCD18824478
68252-72-2
68252-72-2
Acetamide, N-(4-(aminosulfonyl)-2-chlorophenyl)-
AA006CW1 | MFCD01312092
694-34-8
694-34-8
Cyclopropane,2-ethenyl-1,1-difluoro-
AA006DW0 | MFCD08458021
Submit
© 2017 AA BLOCKS, INC. All rights reserved.